Assess Impact of Microdroplet Hyaluronic Acid Filler on Skin Quality in Patients on Glucagon-like Peptide-1 Agonists

Part of paid clinical trials in San Diego, California.

Sponsor
Goldman, Butterwick, Fitzpatrick and Groff
Study ID
NCT07221461
Phase
PHASE2
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Wrinkle

Eligibility Criteria

Sex
FEMALE
Age
25 Years - 50 Years
Healthy Volunteers
Accepted

Interventions

  • Skinvive — DEVICE
    16 GLP1 subjects treated with Skinvive to their cheeks for skin quality will be compared to 8 NON-GLP1 subjects treated with Skinvive for skin quality.

Study Details

Clinical trial to assess the effect of microdroplet hyaluronic acid filler to the cheek skin (SKINVIVE™, JUVÉDERM®, Irvine, CA) on skin quality in patients undergoing medical weight loss with GLP-1 therapy.

Key Dates

Start date
Nov 1, 2025
Status verified
Oct 2025
Primary completion
Jan 30, 2026
Completion
Mar 2, 2026

Study Design

Enrollment
24 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: GLP1 Patients
    16 participants who have been on a stable dose of GLP-1 agonist medication for at least the last 6 months will receive one treatment with microdroplet hyaluronic acid filler (SKINVIVE™, JUVÉDERM®, Irvine, CA) to the cheeks.
  • Experimental: NON GLP1 Patients
    8 participants who are GLP1 naive will receive one treatment with microdroplet hyaluronic acid filler (SKINVIVE™, JUVÉDERM®, Irvine, CA) to the cheeks.

Primary Outcome Measure

Global Fine Lines [ Time Frame: Screening, Day 30, Day 60 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
West Dermatology Research CenterSan DiegoCalifornia92121
Andrea Pacheco
858-657-1004
Freia Canals-Cistero
858-657-1004

Find similar trials in San Diego, CA

Related Studies